{"name":"Athos Therapeutics Inc","slug":"athos-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ATH-063","genericName":"ATH-063","slug":"ath-063","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ATH-063","genericName":"ATH-063","slug":"ath-063","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1kNThzU1RrU09sakFCdlJaOXVVZnZhcjg2OXpIajhaMEk4N25DaF95YXo0Tk9ZakdYRl92bnBLcXZmdkZJaG1YZzVCSFVmSFRmdHpybHhTMEdVQTJQZFNDb1dXYzExZw?oc=5","date":"2025-10-30","type":"pipeline","source":"MedPage Today","summary":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC - MedPage Today","headline":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPd3AxNUxra3FrV0gyRE9ZUlc2OFhfbzdfQ3o4dE1pY2otcTRoOVRTLUtCNUFkb1dzWE1tWTZwVmhSeWlzMThtRHdKbXIwSXRSQ0ZyTVRwajRsUWhHejB0X2U2dlNxNDFmdmFLcHd4cjFrblRrb0x0Sy1VRGd0VEtqN1BvUU1WTC1xQ2pXa0VDdjlhcE85QVpfdFBTQ2ZpNkV3WEtBWTJGM2dQTzItRm5jX2pfbnktWUVyVWJlQ05QZm9YcGc?oc=5","date":"2025-09-11","type":"pipeline","source":"SynBioBeta","summary":"MRM Health Secures €55 Million in Series B Financing to Propel Microbiome-Based Therapeutics - SynBioBeta","headline":"MRM Health Secures €55 Million in Series B Financing to Propel Microbiome-Based Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNR3U2Tk16eVFMcjdTQWVJSDFpRzQ1Q0JaOUhHckxEOUtVUlVBX0xqc0FPTnB0YUtaeXhZOUxUazBlNnp6ZVhaU2tKcGVsaWxEMEJPTUtzY1JnbG5aNldld0hvU2wyZmJ5TGEtM1JMZ292Ynk1ZWhmaDRtWEN5Z2stclRB?oc=5","date":"2025-05-09","type":"pipeline","source":"Pharmaceutical Technology","summary":"Haya secures $65m in Series A funds to advance heart failure treatment - Pharmaceutical Technology","headline":"Haya secures $65m in Series A funds to advance heart failure treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxOeE1iZU52czNxSDE1Y1BFbGFzek1kRWphODEyUW5Qb21YaHM0SEZJWmJ2LUhqWnd4MWtQcDNRcEZYSHZYZ0p5UWdEa1E4ZWxZMFlRNjhzb1AyM3FqaWFHb25CZm1DX2JpSWE1WmhCQzNaYjBCVk83R2tsZ2kwcURGTlNiOVh1X1RiSUw2dkVKbDNJZlpDM2hXTjJxNmh6aXIzR2VJVkFvY2EzWEY5bUF0RnYyTFBSSlpTd1dpRDVXVktOR0FqMEhLRVUxUDFUTjU3RHJNTm1FOVFINTV0T1liZ0dfVGp0LUNrdjFnX0FwVEU5aUd5cHFkYnhFLS1yLXVqVktwXzhpaVJfODcyS3pWZXN3MC1UcUVkdmxMNm81SQ?oc=5","date":"2025-05-08","type":"pipeline","source":"Business Wire","summary":"HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases - Business Wire","headline":"HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxQbGdvVFdOQkQyQ016WmtQQ2ZTRU81cWE1VnFFNnFMd2t5bU41Nzh6UURXcVk1YkRHWGkxYlFsMzU1U3VKYnBobGgxSUNBRXZ2VmZiaXhqUnRsclhZbTBIVURxSlF0UmZDM3I4R2E2M0pqcUdSRTdDdDlJdi16QjBCZWU2SzJlalVnXzd1M2kyVFVBaDZ0Rmp1ZlBDeEUtY0FSOHUzN1hiSjAtSWdXN1NWQnZDTE9nbXJGb1VSUkdEQmJFV1ZTcTRkb3lVMVFkcWJyM1ljQTBYSWh1M3BwaTBoMFFVYWJuRHNTYlNjNA?oc=5","date":"2025-04-15","type":"pipeline","source":"PR Newswire UK","summary":"Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight - PR Newswire UK","headline":"Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPazhYVm5sSmFwTmdrUFFva0hzazEwdnpmdTB2aUJ5UEtZNXNuMVp2YXZ6TktYUjhoR0VzdWcwajJvcFpJMV9IRmZKN2FHbXhGdkp5Rm9YX0hiUHAyWldFZkNIXzBUaTh1X09wcGlhVC1yb0hOdEtqMGhhcWhRNUtoNEV5SWpnMWNqTG1kNw?oc=5","date":"2024-02-13","type":"deal","source":"Yahoo Finance","summary":"Laurence Stein, Former Partner and Managing Director of Goldman Sachs, Appointed to the Board of Directors of Athos Therapeutics - Yahoo Finance","headline":"Laurence Stein, Former Partner and Managing Director of Goldman Sachs, Appointed to the Board of Directors of Athos Ther","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBWcGFGZTZNSlJXdXZKQk9HUkU1cUVsT3dKX2VJSWIybWpwLXd4SFZjOGxYR2x6YzBrMV9CVGlQMDRsMVJqaW9nYVItbVlfY1ozdjNkbmVQeVZleVlUUXZJU053eUJtdE1Fb1E?oc=5","date":"2022-04-16","type":"pipeline","source":"Wiley Online Library","summary":"Editorial: shedding new light on extraintestinal manifestations in inflammatory bowel disease - Wiley Online Library","headline":"Editorial: shedding new light on extraintestinal manifestations in inflammatory bowel disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNQV81RDNfWnFnMWxXWVBSYnVaY3V6ejN3MjNLZ3NFRnA1TTI4d0dmd2V3SWpDMHloZHRJTE9lMlV0aURwNnJwb1VKeEQ3X011OVdpRlhkY203bFZad294Tlc3SnRJdGNtZFVLbmpydHlnQmwtTXI3cm5IZ0MyemV1eGkxQjNwQzZQbndQSWdaZ2hJcFhjSGxMeE5BQzA0Y29oMndZaEZpcmFGem9ERU45aTV6aFA2REd5WWVyNjAxdUM3OVpTSzE5ejFkYnptcUJjc21kd0V5Zw?oc=5","date":"2021-11-15","type":"pipeline","source":"PR Newswire","summary":"Athos Therapeutics Announces the Completion of its Oversubscribed Series A Financing - PR Newswire","headline":"Athos Therapeutics Announces the Completion of its Oversubscribed Series A Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQbElBaDJxbzZKVUVIcTdXcml6Z2VKZ3BSMGptcjFLTWhVYWV1YzZ2NzVhWnpZZ1JQelJyX09qV0drdlowTTc1eDVRWDRzUUlrMjZxN1FhQUpNVFpBRm9kYktybjdWWTBzN3lWelBZbXRwNDlmUXFqZUM5STVCRElKblVDdUpsbW4tVWFXamVaM3FmU2FXRHpzTVdOaVlVWmNTVEp0ZnZR?oc=5","date":"2020-12-01","type":"pipeline","source":"European Medical Journal","summary":"Ulcerative Colitis: Today, Tomorrow, and the Future - European Medical Journal","headline":"Ulcerative Colitis: Today, Tomorrow, and the Future","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOTWN1bUZsWGVzRFlTS054QlpFSTRlU1lrYkFGQUV1RXA5ZnhTOFRDSUdUeTlDVTk3ZjBQa3d5a2paQ08xX3YzVlp1MFUwUHpya3IwWFlSdkp1bF9HdFowV3NyLTJLRlRzcUw2Rl8wUW4xRmtVbFhfdDVEWndZcC1PSWhSakh3Q3NROTlDbFlLMkpJYTdleE9mWXRZdmJTY000UmFoRmJ3bzFNMGlvUTlN?oc=5","date":"2020-09-02","type":"pipeline","source":"ASCO Daily News","summary":"The Role of Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Front-Line Maintenance Approach Emerges as the Winner - ASCO Daily News","headline":"The Role of Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Front-Line Maintenance Approach Emerges as ","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}